维普中文期刊产品整合服务
48篇 您的检索式:作者名="Mu XL"
    题名 作者 年代 出处 被引量
1Gefitinib - sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in Chinese patients with non - small cell lung cancer显示文摘MU XL LILY ZHANG XT 2005Clin Cancer Res2005,11,12:1
2The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer显示文摘Zhang XT Li LY Mu XL 2005Ann Oncol2005,16,:1
3Evaluation of safety and efficacy of gefitinib (iressa, ZD1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme显示文摘Mu XL Li LY Zhang XT 2004BMC Cancer2004,4,1:1
4Gefitinib-sensitive mutations of the epidermal growth factor receptor tyresine kinase domain in chinese patients with non-smail cell lung cancer 显示文摘Mu XL Li LY Zhang XT 2005Clin Cancer Res2005,11,12:1
5Association of miR- 193b down - regulation and miR - 196a up - regulation with clinieopathologieal features and prognosis in gastric cancer 显示文摘Mu YP Tang S Su XL 2014Asian Pac J Cancer Prev2014,15,20:1
6Polymorphism in pre-miR-30c contributes to gas-tric cancer risk in a Chinese population显示文摘Mu YP Su XL 0,,03:1
7Gefitinib sensitive muta-tions of the epidermal growth factor receptor tyrosine ki-nase domain in Chinese patients with non-small cell lung cancer显示文摘Mu XL Li LY Zhang XT 0,,12:1
8Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer显示文摘] Mu XL Li LY Zhang XT 2005Clin Cancer Res2005,11,12:1
9Diffuse large cell non-Hodgkin lymphoma with pituitary and bilateral adrenal involvement显示文摘Wang XL ZH Mu YM 0,,03:1
10Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer显示文摘Mu XL Li LY Zhang XT 2005Clin Cancer Res2005,11,12:1
11Research progress on nursing care of patients indwelling urinary catheter after radical operation for rectal cancer显示文摘Zhao XL Mu SY Liu Y 2013Chin J Mod Nurs2013,19,16:1
12Polymorphism in pre - miR - 30c contributes to gastric cancer risk in a Chinese population显示文摘Mu YP Su XL 2012Med Oncol2012,29,3:1
13Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cel lung cancer显示文摘Mu XL Li LY Zhang XT 2005Clin Cancer Res2005,11,12:1
14Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in Chinese patients with non-small-cell lung cancer显示文摘Mu XL Li LY Zhang XT 2005Clin Cancer Res2005,11,12:1
15Polymorphism in pre-miR-30c contributes to gastric cancer risk in a Chinese population显示文摘Mu YP Su XL 0,,:1
16Evaluation of safety and efficacy of Gefitinib ('Iressa' ZD1839) as monotherapy in a series of Chinese patients with advanced non-small cell lung cancer:experience from a compassionate-use programme显示文摘MU XL LILY ZHANG XT 2004BMC Cancer2004,4,1:1
17The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer显示文摘Zhang XT Li LY Mu XL 2005Annals of Oncology2005,16,8:1
18Successful laparoscope resection of ectopic insulinoma in duodenohepatic ligament显示文摘Wang XL Mu YM Dou JT 2011Am J Med Sci2011,341,5:1
19Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in Chinese patients with non-small cell lung cancer显示文摘Mu XL Li LY Zhang XT 2005Clin Cancer Res2005,11,2:1
20Evaluation of safety and efficacy of gefitinib(iressa,ZD1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer:experience from a compassionate-use programme显示文摘MU XL LI LY ZHANG XT 2004BMC Canccr2004,4,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费